This article is more than 5 years old. Information may no longer be current.
Cardiometabolic issues related to inflammatory arthritis highlighted at ACR 2016
Click Here to Manage Email Alerts
Autoimmune disorders such as ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis not only cause significant pain and disability related to a patient’s joints, but also increase a patient’s risk for other systemic conditions, including cardiovascular disease, that must be monitored and treated.
Healio Internal Medicine presents the top research on cardiometabolic risk associated with inflammatory arthritis that was presented at the 2016 American College of Rheumatology Annual Meeting.
Cardiovascular risk doubled in patients with RA vs the general population
WASHINGTON — The risk for cardiovascular events in patients with rheumatoid arthritis was approximately double the risk observed in the general population, according to long-term findings presented at the American College of Rheumatology Annual Meeting. Read More.
Statin use linked with reduced mortality among patients with AS and PsA
WASHINGTON — Statin use was associated with a 32% reduction in mortality in a large cohort of patients with ankylosing spondylitis and psoriatic arthritis, according to findings presented at the American College of Rheumatology Annual Meeting. Read More.